Clinical Trial Update: In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir [Phase 4]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 4 study investigating in utero treatment of congenital cytomegalovirus infection with valacyclovir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Drugs mentioned

• Valacyclovir (Valtrex) (Valacyclovir)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Foetuses Infection, Cytomegalovirus (CMV)Infection | Phase 4 | Status: COMPLETED